The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
Open accessAbstract
PURPOSE: To explore in a prospective trial the prognostic value of hypoxia imaging before and during radiochemotherapy in patients with locally advanced head and neck cancer. PATIENTS AND METHODS: Twenty-five patients with stage III/IV head and neck cancer were investigated with [(18)F]-fluoromisonidazole (FMISO) PET/CT at four time points during radiochemotherapy (baseline, 8-10 Gy, 18-20 Gy,50-60 Gy). FMISO PET/CT image parameters were extracted including maximum-tumour-to-background (TBR(max)) and thresholded volume at different TBR ratios. CT volume and baseline FDG-PET/CT image parameters were also included. Parameters at all time points were investigated for their prognostic value with the local-progression-free-survival endpoint (LPFS). Significance was evaluated with multivariate Cox (including clinical parameters) and Log-rank tests. RESULTS: FMISO-image parameters were found to have a strong association with the LPFS endpoint, and were strongest at the week 1 and 2 time points (p = 0.023-0.048 and 0.042-0.061 respectively on multivariate Cox). Parameters measured at baseline were only significant on univariate analysis. None of the clinical parameters, and also FDG- or CT-delineated volumes, were significantly associated with LPFS. CONCLUSION: This prospective, exploratory study demonstrated that FMISO-PET/CT imaging during the initial phase of treatment carries strong prognostic value. FMISO-PET/CT imaging at 1 or 2 weeks during treatment could be promising way to select patients that would benefit from hypoxia modification or dose-escalated treatment. A validation study is on-going.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Joiner, M. C., & van der Kogel, A. (2009) · CRC Press eBooks · doi:10.1201/b15450 · Cited by 1,068
Imaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614
Overgaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 573
Rasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Rischin, D., Hicks, R. J., Fisher, R., Binns, D., Corry, J., Porceddu, S., & Peters, L. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2878 · Cited by 541
Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.03.004 · Cited by 456
Eschmann, S. M., Paulsen, F., Reimold, M., Dittmann, H., Welz, S., Reischl, G., Machulla, H.-J., & Bares, R. (2005) · PubMed · Cited by 400
Rajendran, J. G., Schwartz, D. L., O'Sullivan, J., Peterson, L. M., Ng, P., Scharnhorst, J., Grierson, J. R., & Krohn, K. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1773 · Cited by 354
Overgaard, J., Eriksen, J. G., Nordsmark, M., Alsner, J., & Horsman, M. R. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70292-8 · Cited by 274
Janssens, G. O., Rademakers, S. E., Terhaard, C. H., Doornaert, P. A., Bijl, H. P., van den Ende, P., Chin, A., Marres, H. A., de Bree, R., van der Kogel, A. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.9315 · Cited by 256
Adaptive Radiotherapy for Head-and-Neck Cancer: Initial Clinical Outcomes From a Prospective Trial
Schwartz, D. L., Garden, A. S., Thomas, J., Chen, Y., Zhang, Y., Lewin, J., Chambers, M. S., & Dong, L. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.08.017 · Cited by 246
Held, K. D. (2010) · International Journal of Radiation Biology · doi:10.3109/09553002.2010.496030 · Cited by 241
Grosu, A.-L., Souvatzoglou, M., Röper, B., Dobritz, M., Wiedenmann, N., Jacob, V., Wester, H.-J., Reischl, G., Machulla, H.-J., Schwaiger, M., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.05.079 · Cited by 229
Toustrup, K., Sørensen, B. S., Lassen, P., Wiuf, C., Alsner, J., & Overgaard, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.09.010 · Cited by 221
Dehdashti, F., Grigsby, P. W., Lewis, J. S., Laforest, R., Siegel, B. A., & Welch, M. J. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.048520 · Cited by 212
Sorger, D., Patt, M., Kumar, P., Wiebe, L. I., Barthel, H., Seese, A., Dannenberg, C., Tannapfel, A., & Osama Sabri, R. K. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00442-0 · Cited by 207
Dirix, P., Vandecaveye, V., De Keyzer, F., Stroobants, S., Hermans, R., & Nuyts, S. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.062638 · Cited by 207
ARCON: experience in 215 patients with advanced head-and-neck cancer
Kaanders, J. H. A. M., Pop, L. A. M., Marres, H. A. M., Bruaset, I., van den Hoogen, F. J. A., Merkx, M. A. W., & van der Kogel, A. J. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)02678-5 · Cited by 184
Thorwarth, D., Eschmann, S.-M., Scheiderbauer, J., Paulsen, F., & Alber, M. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-152 · Cited by 169
Yaromina, A., Krause, M., Thames, H. D., Rosner, A., Krause, M., Hessel, F., Grenman, R. A., Zips, D., & Baumann, M. A. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.020 · Cited by 162
Self-citationLee, J. A. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.07.003 · Cited by 159
Lee, N. Y., Nehmeh, S. A., Schöder, H. M., Fury, M. G., Chan, K., Ling, C. C., & Humm, J. L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.10.049 · Cited by 128
Eschmann, S. M., Paulsen, F., Bedeshem, C., Machulla, H., Hehr, T., Bamberg, M., & Bares, R. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.014 · Cited by 120
Minagawa, Y., Shizukuishi, K., Koike, I., Horiuchi, C., Watanuki, K., Hata, M., Omura, M., Odagiri, K., Tohnai, I., Inoue, T., et al. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0471-5 · Cited by 92
Automatic volume delineation in oncological PET
Hofheinz, F., Pötzsch, C., Oehme, L., Beuthien‐Baumann, B., Steinbach, J., Kotzerke, J., & van den Hoff, J. (2011) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-0419-11-07 · Cited by 91
Self-citationKikuchi, M., Yamane, T., Shinohara, S., Fujiwara, K., Hori, S., Tona, Y., Yamazaki, H., Naito, Y., & Senda, M. (2011) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0508-9 · Cited by 89
Yaromina, A., Thames, H. D., Zhou, X., Hering, S., Eicheler, W., Dörfler, A., Leichtner, T., Zips, D., & Baumann, M. A. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.04.020 · Cited by 88
Self-citationNewbold, K. L., Castellano, I. A., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M. O., Rhys‐Evans, P. H., Clarke, P. M., Fisher, C., Harrington, K. J., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.039 · Cited by 88
Stadler, P. F., Feldmann, H. J., Creighton, C., Kau, R. J., & Molls, M. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00032-2 · Cited by 67
Changes in oxygenation during radiotherapy in carcinoma of the cervix
Cooper, R., West, C., Logue, J. P., Davidson, S. E., Miller, A., Roberts, S. A., Stratford, I. J., Honess, D. J., & Hunter, R. D. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00093-0 · Cited by 57
Mönnich, D., Troost, E. G. C., Kaanders, J. H. A. M., Oyen, W. J. G., Alber, M. L., & Thorwarth, D. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/7/009 · Cited by 51
Two or four hour [18F]FMISO-PET in HNSCC: When is the contrast best?
Haase, R., Koch, A., Zips, D., Steinbach, J., Baumann, M. A., Kotzerke, J., Zöphel, K., & Abolmaali, N. (2010) · Nuklearmedizin - NuclearMedicine · doi:10.3413/nukmed-00328-10-07 · Cited by 46
Self-citationHofheinz, F., Pötzsch, C., Oehme, L., Beuthien‐Baumann, B., Steinbach, J., Kotzerke, J., & van den Hoff, J. (2012) · Nuklearmedizin - NuclearMedicine · Cited by 43
Self-citationZwei oder vier Stunden [18F]FMISO-PET in Kopf-Hals-Karzinomen:
Abolmaali, N., Haase, R., Koch, A., et al. (2011) · Nuklearmedizin - NuclearMedicine · Cited by 35
Self-citationBaumann, M. A., Appold, S., Zimmer, J., et al. (2001) · Acta Oncologica · doi:10.1080/028418601750288262 · Cited by 28
Self-citation
Cited by
Radiation oncology in the era of precision medicine
Baumann, M., Krause, M., Overgaard, J., Debus, J., Bentzen, S. M., Daartz, J., Richter, C., Zips, D., & Bortfeld, T. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.18 · Cited by 812
Self-citationImaging hypoxia to improve radiotherapy outcome
Horsman, M. R., Mortensen, L. S., Petersen, J. B., Busk, M., & Overgaard, J. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.171 · Cited by 614
Walsh, J. C., Lebedev, A., Aten, E., Madsen, K., Marciano, L., & Kolb, H. C. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5378 · Cited by 420
Krause, M., Dubrovska, A., Linge, A., & Baumann, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.002 · Cited by 305
Self-citationTargeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
Salem, A., Asselin, M.-C., Reymen, B., Jackson, A., Lambin, P., West, C. M. L., O’Connor, J. P. B., & Faivre-Finn, C. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx160 · Cited by 266
Metadata
- Authors
- Zips, D., Zöphel, K., Abolmaali, N., Perrin, R., Abramyuk, A., Haase, R., Appold, S., Steinbach, J., Kotzerke, J., & Baumann, M.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 105
- Issue
- 1
- Pages
- 21-28
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2066210329
- Cited by
- 280
- References
- 35
- FWCI
- 23.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.